Citations

Mayo Clinic

Showing 10 of 108599 citations.

Introduction to the Centers for Disease Control and Prevention and Healthcare Infection Control Practices Advisory Committee Guideline for Prevention of Surgical Site Infection: Prosthetic Joint Arthroplasty Section
Segreti, John , Berbari, Elie F. , Ricks, Philip, Berríos-Torres, Sandra I., Berbari, Elie, Parvizi, Javad

Surgical Infections | April 13, 2017 | Volume: 18 | Issue: 4 | Pages: 394-400

10.1089/sur.2017.068 | PMID 28407472 Get It

Brief Report: Robo1 Regulates the Migration of Human Subventricular Zone Neural Progenitor Cells During Development
Guerrero‐Cazares, Hugo , Lavell, Emily , Chen, Linda , Schiapparelli, Paula , Lara‐Velazquez, Montserrat , Capilla‐González, Vivian , Clements, Anna Christina , Drummond, Gabrielle, Noiman, Liron, Thaler, Katrina, Burke, Anne E. , Quiñones‐Hinojosa, Alfredo , Capilla-González, Vivian , Guerrero-Cazares, Hugo

Stem Cells | April 13, 2017 | Volume: 35 | Issue: 7 | Pages: 1860-1865

10.1002/stem.2628 | PMID 28406573 Get It

Abstract Human neural progenitor cell (NPC) migration within the subventricular zone (SVZ) of the lateral ganglionic eminence is an active process throughout early brain development. The migration of human NPCs from the SVZ to the olfactory bulb during fetal stages resembles what occurs in adult rodents. As the human brain develops during infancy, this migratory stream is drastically reduced in cell number and becomes barely evident in adults. The mechanisms regulating human NPC migration are unknown. The Slit–Robo signaling pathway has been defined as a chemorepulsive cue involved in axon guidance and neuroblast migration in rodents. Slit and Robo proteins expressed in the rodent brain help guide neuroblast migration from the SVZ through the rostral migratory stream to the olfactory bulb. Here, we present the first study on the role that Slit and Robo proteins play in human-derived fetal neural progenitor cell migration (hfNPC). We describe that Robo1 and Robo2 isoforms are expressed in the human fetal SVZ. Furthermore, we demonstrate that Slit2 is able to induce a chemorepellent effect on the migration of hfNPCs derived from the human fetal SVZ. In addition, when Robo1 expression is inhibited, hfNPCs are unable to migrate to the olfactory bulb of mice when injected in the anterior SVZ. Our findings indicate that the migration of human NPCs from the SVZ is partially regulated by the Slit–Robo axis. This pathway could be regulated to direct the migration of NPCs in human endogenous neural cell therapy.
An Early Assessment of the ACGME CLER Program: A National Survey of Designated Institutional Officials
Long, Timothy R. , Doherty, Julie, Frimannsdottir, Katrin R., Rose, Steven H.

Journal of Graduate Medical Education | April 13, 2017 | Volume: 9 | Issue: 3 | Pages: 330-335

10.4300/jgme-d-16-00489.1 | PMID 28638512 Get It

ABSTRACT Background The Accreditation Council for Graduate Medical Education (ACGME) Clinical Learning Environment Review (CLER) is an innovative element of the ACGME's new accreditation system. To date, little information has been collected regarding the value of CLER. Objective The purpose of this study is to collect information on designated institutional officials' (DIOs') perspectives about the initial CLER visits conducted at their institutions. Methods The authors created and distributed a survey to DIOs about their initial CLER visits. Demographic data were compared across survey responses with Spearman's rank correlation and the Kruskal-Wallis test. Results The authors received responses from 63% of DIOs (186 of 297) at institutions that participated in the initial CLER visits, with 88% (164 of 186) having served as DIO during the visit. Seventy-two percent (114 of 158) reported institutional changes to address CLER focus areas prior to the visit, yet only 32% (51 of 157) reported that additional resources were allocated to these areas after the site visit. Sixty-five percent (102 of 156) reported institutional executive leadership was positive about participating in CLER; 85% (134 of 158) reported that ACGME conducted the visits efficiently; 84% (133 of 158) reported that the site visit accurately assessed the institution's performance in the CLER focus areas; and 60% (93 of 156) reported CLER provided high-value information. Conclusion Survey results from DIOs suggest that CLER is an effective mechanism to improve the learning environment. Common concerns included limited advance notice for the site visit and disruptions of clinical practice.
Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology
Ezzati, Ali , Wang, Cuiling , Altschul, Dorothea , Katz, Mindy J. , Lipton, Richard B. , Dickson, Dennis W. , Derby, Carol A.

Journal of the American Geriatrics Society | April 13, 2017 | Volume: 65 | Issue: 8 | Pages: 1836-1841

10.1111/jgs.14903 | PMID 28407205 Get It

Objectives To examine the association between vascular pathology and rate of cognitive decline in older adults independent of Alzheimer's disease ( AD ) pathology. Design Prospective cohort study. Setting Community sample. Participants Individuals from the Einstein Aging Study autopsy series (N = 62). Measurements The Blessed Information‐Memory‐Concentration ( BIMC ) test was used to assess global cognitive status. AD pathology was quantified according to Braak stage (<3 vs ≥ 3). Vascular pathology was quantified using a previously reported macrovascular lesion ( MVL ) score. The association between vascular pathology and antemortem rates of cognitive decline adjusted for level of AD pathology was assessed using linear mixed‐effects models. Results Mean age was 81.8 at enrollment and 89.0 at death. Participants with more than two MVL s had faster cognitive decline than those with no MVL s (difference in annual rate of change in BIMC 0.74 points/yr, P = .03). Braak stage was also associated with cognitive decline (difference 0.57 points/yr, P = .03). The difference in rate of cognitive decline between those with more than two MVL s and those free of vascular lesions persisted after adjustment for AD pathology (difference in rate of change in BIMC 0.68 points/yr, P = .04). The effect of vascular pathology on cognitive decline was not significantly different according to AD pathology. Conclusion Vascular brain pathology is associated with rate of cognitive decline after adjusting for level of AD pathology.
Functionalized Carbon Nanotube and Graphene Oxide Embedded Electrically Conductive Hydrogel Synergistically Stimulates Nerve Cell Differentiation
Liu, Xifeng , Park, Sungjo , Waletzki, Brian E., Zhou, Zifei , Lu, Lichun , Miller, A. Lee , Miller, Alan Lee , Terzic, André

ACS Applied Materials & Interfaces | April 13, 2017 | Volume: 9 | Issue: 17 | Pages: 14677-14690

10.1021/acsami.7b02072 | PMID 28406608 Get It

The yin and yang of autophagy in AL amyloidosis
Dispenzieri, Angela

Blood | April 13, 2017 | Volume: 129 | Issue: 15 | Pages: 2044-2045

10.1182/blood-2017-02-765594 | PMID 28408419 Get It

Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma
Rolfes, Mary , Juhn, Young J. , Sheen, Youn Ho, Juhn, Young Jun, Wi, Chung‐Il

Tuberculosis and Respiratory Diseases | April 13, 2017 | Volume: 80 | Issue: 2 | Pages: 113

10.4046/trd.2017.80.2.113 | PMID 28416952 Get It

Mesenchymal Stem Cell-derived Extracellular Vesicles for Renal Repair
Nargesi, Arash Aghajani , Lerman, Lilach O. , Eirin, Alfonso , Eirin, Alfonso

Current Gene Therapy | April 13, 2017 | Volume: 17 | Issue: 1 | Pages: No page available

10.2174/1566523217666170412110724 | PMID 28403795 Get It

A Methodology to Compare Insulin Dosing Recommendations in Real-Life Settings
Groat, Danielle , Thompson, Bithika , Neto, Pedro Cunha Mendes , Soni, Hiral , Boyle, Mary E., Bailey, Marilyn, Grando, Maria A, Cook, Curtiss B. , Grando, Adela

Journal of Diabetes Science and Technology | April 13, 2017 | Volume: 11 | Issue: 6 | Pages: 1174-1182

10.1177/1932296817704444 | PMID 28406039 Get It

Background: We propose a methodology to analyze complex real-life glucose data in insulin pump users. Methods: Patients with type 1 diabetes (T1D) on insulin pumps were recruited from an academic endocrinology practice. Glucose data, insulin bolus (IB) amounts, and self-reported alcohol consumption and exercise events were collected for 30 days. Rules were developed to retrospectively compare IB recommendations from the insulin pump bolus calculator (IPBC) against recommendations from a proposed decision aid (PDA) and for assessing the PDA’s recommendation for exercise and alcohol. Results: Data from 15 participants were analyzed. When considering instances where glucose was below target, the PDA recommended a smaller dose in 14%, but a larger dose in 13% and an equivalent IB in 73%. For glucose levels at target, the PDA suggested an equivalent IB in 58% compared to the subject’s IPBC, but higher doses in 20% and lower in 22%. In events where postprandial glucose was higher than target, the PDA suggested higher doses in 25%, lower doses in 13%, and equivalent doses in 62%. In 64% of all alcohol events the PDA would have provided appropriate advice. In 75% of exercise events, the PDA appropriately advised an IB, a carbohydrate snack, or neither. Conclusions: This study provides a methodology to systematically analyze real-life data generated by insulin pumps and allowed a preliminary analysis of the performance of the PDA for insulin dosing. Further testing of the methodological approach in a broader diabetes population and prospective testing of the PDA are needed.
Critical Diagnoses in Forensic Pathology: Ethics of Disclosure
Blessing, Melissa M. , Reichard, R. Ross

Academic Forensic Pathology | April 13, 2017 | Volume: 3 | Issue: 3 | Pages: 289-293

10.23907/2013.038 Get It

A complex set of systems exists in the United States to manage and regulate the practice of medicine, and forensic pathologists (FPs) are bound by the associated ethical guidelines and associated statutory obligations. Individual FPs, for example, are required to have and maintain a state medical license that requires continuing medical education and provides oversight of many aspects of the practice of medicine. The laboratories in which forensic pathology is practiced, however, generally do not have to be accredited. In contrast, the College of American Pathologists (CAP) is the recognized accrediting body that “regulates” the majority of anatomic pathology and laboratory medicine, including hospital (consented) autopsies. Unlike hospital-based pathology practices, few incentives are present that encourage or require forensic pathology practices to pursue accreditation. Since the preponderance of forensic pathology practices do not fall under the purview of CAP, this relatively small subset of pathologists are left to determine their own set of professional and ethical standards. The National Association of Medical Examiners (NAME) laboratory accreditation and published autopsy guidelines provides a foundation for development of a quality management program, but does not specifically address disclosure of test results. Defining “critical diagnoses” in forensic pathology is challenging, and communicating these important findings to the proper individual(s) or organizations may not fall under statutory or accrediting requirements, and thus may become an ethical issue for the medical examiner/coroner.